Maria Elvira Salazar
RHouseRepresentative · Florida
Sold up to $50,000 of Amgen (AMGN)
Trade dated Apr 17, 202621 days to disclose
AMGN since the sale
-2.7%
S&P 500, same window
+6.6%
▼ AMGN trailed the S&P 500 by 9.3 points since the sale
Price move from the trade date's close to the most recent close. A sale is favorable when the stock fell after.
On the public record around this trade
Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.
- Apr 14, 2026LegislationPharmaceutical sector
- Apr 14, 2026LegislationPharmaceutical sector
- Apr 15, 2026LegislationPharmaceutical sector
- Apr 16, 2026Floor voteResult: Passed
- Apr 17, 2026TradeSold up to $50,000 of AMGN
- Apr 20, 2026LegislationPharmaceutical sector
- Apr 20, 2026LegislationPharmaceutical sector
- Apr 21, 2026Floor voteResult: Passed
- Apr 27, 2026Floor voteResult: Passed
- May 8, 2026DisclosureDisclosed the tradePublic filing
- May 20, 2026CommitteeFY2027 Budget Request: State Department Adjacent Entities
- May 20, 2026CommitteeConfronting the Totalitarian Ortega-Murillo Regime
- May 20, 2026CommitteeFrom Order to Execution: Ensuring Efficient and Transparent Equity Markets
Get an alert the moment Maria Elvira Salazar files the next one
Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.